La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Cardinal Health Gestion
Gestion contrôle des critères 0/4
Le PDG Cardinal Health's est Jason Hollar, nommé en Sep2022, a un mandat de 1.92 ans. La rémunération annuelle totale est $ 18.78M, composée du salaire de 6.6% et des bonus 93.4%, y compris les actions et options de la société. détient directement 0.04% des actions de la société, d'une valeur de $ 10.81M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 2 ans et 3 ans.
Informations clés
Jason Hollar
Directeur général
US$18.8m
Rémunération totale
| Pourcentage du salaire du PDG | 6.6% |
| Durée du mandat du directeur général | 1.9yrs |
| Propriété du PDG | 0.04% |
| Durée moyenne d'occupation des postes de direction | 2yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 3yrs |
Mises à jour récentes de la gestion
Recent updates
Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.5056
Aug 19
Cardinal Health: Growth Headwinds Ahead
Aug 01Cardinal Health: Growing Into The Valuation
Jul 02Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056
Jun 11Cardinal Health's Valuation Makes The Name Unattractive
May 26Cardinal Health Q3 Earnings: Undervalued On Strong Guidance
May 03Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk
Apr 14Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?
Mar 09Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration
Feb 20Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Feb 03Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues
Dec 28Cardinal Health Is Setting Up For A Great 2024
Dec 21Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate
Nov 03Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity
Oct 13Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation
Aug 07Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue
Aug 05An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued
Jul 14Cardinal Health: Not A Long-Term Investment
May 24The Return Trends At Cardinal Health (NYSE:CAH) Look Promising
Apr 17Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price
Mar 30Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)
Feb 21Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957
Feb 16Cardinal Health declares $0.4957 dividend
Feb 10Cardinal Health FQ2 2023 Earnings Preview
Feb 01Cardinal Health partners with Palantir for data-driven supply chain support
Jan 26Cardinal Health Is A Tempting Healthcare Income Play
Dec 28Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957
Dec 20Aaron Alt is the new finance chief at Cardinal health
Dec 19Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?
Dec 14Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Nov 16Cardinal Health: Investable In Potential Pullback Despite Weak Medical Segment
Nov 14Cardinal Health rises on Q1 earnings beat
Nov 04Cardinal Health Is Being Undervalued, Has Significant Upside In The Near Term
Oct 10Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Sep 29Cardinal Health: Aristocrat Heading For A Makeover
Sep 26PayrHealth to collaborate with Cardinal Health
Sep 15Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$852m |
| Mar 31 2024 | n/a | n/a | US$552m |
| Dec 31 2023 | n/a | n/a | US$639m |
| Sep 30 2023 | n/a | n/a | US$156m |
| Jun 30 2023 | US$19m | US$1m | US$330m |
| Mar 31 2023 | n/a | n/a | US$463m |
| Dec 31 2022 | n/a | n/a | -US$1b |
| Sep 30 2022 | n/a | n/a | -US$1b |
| Jun 30 2022 | US$4m | US$729k | -US$938m |
| Mar 31 2022 | n/a | n/a | -US$955m |
| Dec 31 2021 | n/a | n/a | US$555m |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | US$4m | US$700k | US$611m |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | n/a | n/a | US$1b |
| Sep 30 2020 | n/a | n/a | US$973m |
| Jun 30 2020 | US$4m | US$124k | -US$4b |
Rémunération vs marché: La rémunération totale de Jason ($USD 18.78M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 13.21M ).
Rémunération et revenus: La rémunération de Jason a augmenté de plus de 20 % au cours de l'année écoulée.
PDG
Jason Hollar (51 yo)
1.9yrs
Titularisation
US$18,776,433
Compensation
Mr. Jason M. Hollar has been Chief Executive Officer of Cardinal Health, Inc. since September 01, 2022. He serves as Director at Cardinal Health, Inc. from August 11, 2022 and had been Chief Financial Offi...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Director | 1.9yrs | US$18.78m | 0.035% $ 9.4m | |
| Chief Financial Officer | 1.5yrs | US$6.00m | 0.0013% $ 334.2k | |
| Chief Legal & Compliance Officer | 5.4yrs | US$4.40m | 0.023% $ 6.1m | |
| Chief Executive Officer of Medical Segment | 5yrs | US$4.42m | 0.017% $ 4.5m | |
| Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment | 1.9yrs | US$4.07m | 0.020% $ 5.5m | |
| Senior Vice President | 1.5yrs | US$1.26m | 0.0020% $ 542.8k | |
| Senior VP & Chief Accounting Officer | 1.9yrs | pas de données | 0.0050% $ 1.3m | |
| Executive VP | 2yrs | pas de données | 0.0079% $ 2.1m | |
| Vice President of Investor Relations | no data | pas de données | pas de données | |
| Chief Human Resources Officer | 5.8yrs | pas de données | 0.011% $ 3.0m | |
| Executive Vice President of Biopharma Solutions & Strategic Sourcing | no data | pas de données | pas de données | |
| President of Global Products & Supply Chain | 3.4yrs | pas de données | pas de données |
2.0yrs
Durée moyenne de l'emploi
52.5yo
Âge moyen
Gestion expérimentée: L'équipe de direction de CAH n'est pas considérée comme expérimentée (ancienneté moyenne 2 ans), ce qui suggère une nouvelle équipe.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Director | 2yrs | US$18.78m | 0.035% $ 9.4m | |
| Independent Non-Executive Chairman | 17yrs | US$553.58k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$310.03k | 0% $ 0 | |
| Independent Director | 10.9yrs | US$320.03k | 0.0045% $ 1.2m | |
| Independent Director | 4.1yrs | US$302.03k | 0% $ 0 | |
| Independent Director | 3.9yrs | US$319.95k | 0.0017% $ 446.5k | |
| Independent Director | 8.9yrs | US$300.03k | 0% $ 0 | |
| Independent Director | 6.5yrs | US$325.03k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$310.03k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$310.03k | 0.00019% $ 50.8k | |
| Independent Director | less than a year | pas de données | pas de données | |
| Independent Director | 1.9yrs | US$310.03k | 0.00023% $ 61.5k |
3.0yrs
Durée moyenne de l'emploi
61yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de CAH ne sont pas considérés comme expérimentés (ancienneté moyenne 3 ans), ce qui suggère un nouveau conseil d'administration.